On this page
Read the experiment
The finding and its boundary
The authors reported attenuation of drug-associated pressure changes with BPC-157. The result is not evidence that BPC-157 prevents medication-related reflux in patients.
Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.
- Experiment
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Study system
- Rats receiving dopamine antagonists and nitric-oxide modifiers
- Measured outcome
- Manometric pressures in lower-esophageal and pyloric sphincters
- Reported result
- The authors reported attenuation of drug-associated pressure changes with BPC-157.
- What this cannot establish
- The result is not evidence that BPC-157 prevents medication-related reflux in patients.
What was actually tested
Rats receiving dopamine antagonists and nitric-oxide modifiers. The investigators measured manometric pressures in lower-esophageal and pyloric sphincters. The authors reported attenuation of drug-associated pressure changes with BPC-157.
The detail that changes the takeaway
The measured outcome is an animal pressure response rather than symptom control during human treatment. Central and peripheral drugs are grouped mechanistically, but the clinical indications remain different. Their effects should not be treated as a single side effect that another compound reliably removes.
How far the result travels
The result is not evidence that BPC-157 prevents medication-related reflux in patients.
A useful comparison
Vascular outcomes after dopamine-related drug challenges examines rapid hemodynamic, thrombotic and multiorgan outcomes. Here, the measured endpoint was manometric pressures in lower-esophageal and pyloric sphincters. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and esophagitis: a sphincter experiment is not evidence for everyday reflux care appraisal.
References & product documents
The evidence and service information used here.